USP9YP32

Across TCGA pan-cancer cohorts, USP9YP32 RNA is linked to patient survival in 3 of 34 cancer types, making it the most broadly survival-associated USP9YP32 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher USP9YP32 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated USP9YP32 expression acts as an unfavorable survival marker.

STAD, ESCA, and SARC are the cancer types where USP9YP32 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	DFS	Tertile	III,IV	0.312	0.617	.025	36	view →
ESCA	DFS	Tertile	III,IV	0.023	0.443	<.001	18	view →
SARC	DFS	Tertile	All	0.098	0.611	.006	18	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

USP9YP32–STAD (DFS)

Open the STAD breakdown →